{"id":"https://openalex.org/W2104239201","doi":"https://doi.org/10.3389/fnbeh.2014.00290","title":"A mouse model of non-motor symptoms in Parkinson's disease: focus on pharmacological interventions targeting affective dysfunctions","display_name":"A mouse model of non-motor symptoms in Parkinson's disease: focus on pharmacological interventions targeting affective dysfunctions","publication_year":2014,"publication_date":"2014-08-27","ids":{"openalex":"https://openalex.org/W2104239201","doi":"https://doi.org/10.3389/fnbeh.2014.00290","mag":"2104239201","pmid":"https://pubmed.ncbi.nlm.nih.gov/25221486","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4145811"},"language":"en","primary_location":{"id":"doi:10.3389/fnbeh.2014.00290","doi":"https://doi.org/10.3389/fnbeh.2014.00290","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fnbeh.2014.00290","pdf_url":"https://www.frontiersin.org/articles/10.3389/fnbeh.2014.00290/pdf","source":{"id":"https://openalex.org/S76576941","display_name":"Frontiers in Behavioral Neuroscience","issn_l":"1662-5153","issn":["1662-5153"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Behavioral Neuroscience","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2104239201"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fnbeh.2014.00290/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5105344350","display_name":"Alessandra Bonito-Oliva","orcid":"https://orcid.org/0000-0003-4269-9676","observed_orcids":["https://orcid.org/0000-0003-4269-9676"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Alessandra Bonito-Oliva","raw_affiliation_strings":["Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029236024","display_name":"D\u00e9bora Masini","orcid":"https://orcid.org/0000-0003-1467-2388","observed_orcids":["https://orcid.org/0000-0003-1467-2388"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"D\u00c3\u00a9bora Masini","raw_affiliation_strings":["Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036646593","display_name":"Gilberto Fisone","orcid":"https://orcid.org/0000-0002-0719-8000","observed_orcids":["https://orcid.org/0000-0002-0719-8000"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Gilberto Fisone","raw_affiliation_strings":["Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5036646593"],"corresponding_institution_ids":["https://openalex.org/I28166907"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":6.8085,"has_fulltext":true,"cited_by_count":179,"citation_normalized_percentile":{"value":0.97566093,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"8","issue":null,"first_page":"290","last_page":"290"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.003700000001117587,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10919","display_name":"Deep Brain Stimulation and Movement Disorders","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9919999837875366},{"id":"https://openalex.org/keywords/non-motor-symptoms","display_name":"non-motor symptoms","score":0.9980000257492065},{"id":"https://openalex.org/keywords/6-ohda-lesion","display_name":"6-hydroxydopamine lesion","score":0.890999972820282},{"id":"https://openalex.org/keywords/dorsal-striatum","display_name":"dorsal striatum","score":0.8820000290870667},{"id":"https://openalex.org/keywords/mouse-model","display_name":"mouse model","score":0.7730000019073486},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.6919999718666077},{"id":"https://openalex.org/keywords/anxiety","display_name":"anxiety","score":0.722000002861023},{"id":"https://openalex.org/keywords/anosmia","display_name":"anosmia","score":0.8939999938011169},{"id":"https://openalex.org/keywords/odor-discrimination","display_name":"odor discrimination","score":0.9729999899864197},{"id":"https://openalex.org/keywords/l-dopa","display_name":"L-DOPA","score":0.8560000061988831},{"id":"https://openalex.org/keywords/pramipexole","display_name":"pramipexole","score":0.9940000176429749},{"id":"https://openalex.org/keywords/reboxetine","display_name":"reboxetine","score":0.8180000185966492},{"id":"https://openalex.org/keywords/noradrenaline-reuptake-inhibition","display_name":"norepinephrine reuptake inhibition","score":0.824999988079071},{"id":"https://openalex.org/keywords/dopamine-d2-3-receptors","display_name":"dopamine D2/D3 receptors","score":0.8420000076293945},{"id":"https://openalex.org/keywords/desipramine","display_name":"desipramine","score":0.7760000228881836},{"id":"https://openalex.org/keywords/noradrenergic-terminals","display_name":"noradrenergic terminals","score":0.6800000071525574}],"concepts":[{"id":"https://openalex.org/C2779085643","wikidata":"https://www.wikidata.org/wiki/Q7096029","display_name":"Open field","level":2,"score":0.7084265351295471},{"id":"https://openalex.org/C136569192","wikidata":"https://www.wikidata.org/wiki/Q4880745","display_name":"Behavioural despair test","level":4,"score":0.6922129988670349},{"id":"https://openalex.org/C205044023","wikidata":"https://www.wikidata.org/wiki/Q4778117","display_name":"Anxiogenic","level":4,"score":0.6861954927444458},{"id":"https://openalex.org/C2910500303","wikidata":"https://www.wikidata.org/wiki/Q949618","display_name":"Thigmotaxis","level":3,"score":0.65748131275177},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5249233841896057},{"id":"https://openalex.org/C2781156865","wikidata":"https://www.wikidata.org/wiki/Q827023","display_name":"Lesion","level":2,"score":0.49806809425354004},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.46225661039352417},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.432238906621933},{"id":"https://openalex.org/C173586616","wikidata":"https://www.wikidata.org/wiki/Q5359685","display_name":"Elevated plus maze","level":3,"score":0.427977979183197},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.42033955454826355},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.407917857170105},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3827705383300781},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.3102940320968628},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.20503291487693787},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.1987285017967224},{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.10599488019943237}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fnbeh.2014.00290","doi":"https://doi.org/10.3389/fnbeh.2014.00290","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fnbeh.2014.00290","pdf_url":"https://www.frontiersin.org/articles/10.3389/fnbeh.2014.00290/pdf","source":{"id":"https://openalex.org/S76576941","display_name":"Frontiers in Behavioral Neuroscience","issn_l":"1662-5153","issn":["1662-5153"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Behavioral Neuroscience","raw_type":"journal-article"},{"id":"pmid:25221486","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25221486","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in behavioral neuroscience","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4145811","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4145811/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Behav Neurosci","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:1c7d29506b5c488e9b61606ef073e3ef","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/1c7d29506b5c488e9b61606ef073e3ef","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Behavioral Neuroscience, Vol 8 (2014)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fnbeh.2014.00290","doi":"https://doi.org/10.3389/fnbeh.2014.00290","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fnbeh.2014.00290","pdf_url":"https://www.frontiersin.org/articles/10.3389/fnbeh.2014.00290/pdf","source":{"id":"https://openalex.org/S76576941","display_name":"Frontiers in Behavioral Neuroscience","issn_l":"1662-5153","issn":["1662-5153"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Behavioral Neuroscience","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G8153300672","display_name":null,"funder_award_id":"13482","funder_id":"https://openalex.org/F4320322581","funder_display_name":"Vetenskapsr\u00e5det"},{"id":"https://openalex.org/G8690531480","display_name":null,"funder_award_id":"13482","funder_id":"https://openalex.org/F4320322315","funder_display_name":"Karolinska Institutet"}],"funders":[{"id":"https://openalex.org/F4320321091","display_name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","ror":"https://ror.org/00x0ma614"},{"id":"https://openalex.org/F4320322315","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691"},{"id":"https://openalex.org/F4320322581","display_name":"Vetenskapsr\u00e5det","ror":"https://ror.org/03zttf063"},{"id":"https://openalex.org/F4320323375","display_name":"\u00c5hl\u00e9n-stiftelsen","ror":"https://ror.org/00gsykk45"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2104239201.pdf","grobid_xml":"https://content.openalex.org/works/W2104239201.grobid-xml"},"referenced_works_count":73,"referenced_works":["https://openalex.org/W1493305388","https://openalex.org/W1512804011","https://openalex.org/W1522048223","https://openalex.org/W1573822259","https://openalex.org/W1587617457","https://openalex.org/W1596038879","https://openalex.org/W1964642241","https://openalex.org/W1964668480","https://openalex.org/W1972106608","https://openalex.org/W1972927648","https://openalex.org/W1975759687","https://openalex.org/W1978590350","https://openalex.org/W1979285338","https://openalex.org/W1982501060","https://openalex.org/W1982625279","https://openalex.org/W1986433233","https://openalex.org/W1987297132","https://openalex.org/W1989123455","https://openalex.org/W1990894640","https://openalex.org/W1992633971","https://openalex.org/W1993271363","https://openalex.org/W1999487060","https://openalex.org/W2002354852","https://openalex.org/W2004208654","https://openalex.org/W2005594217","https://openalex.org/W2008119714","https://openalex.org/W2010206955","https://openalex.org/W2017110351","https://openalex.org/W2019920591","https://openalex.org/W2022153650","https://openalex.org/W2023581663","https://openalex.org/W2027845654","https://openalex.org/W2028620130","https://openalex.org/W2029624330","https://openalex.org/W2032058764","https://openalex.org/W2035738053","https://openalex.org/W2038591480","https://openalex.org/W2042158944","https://openalex.org/W2044400428","https://openalex.org/W2054087453","https://openalex.org/W2057668497","https://openalex.org/W2059389314","https://openalex.org/W2065337015","https://openalex.org/W2065643355","https://openalex.org/W2065673659","https://openalex.org/W2069552953","https://openalex.org/W2071053556","https://openalex.org/W2073449985","https://openalex.org/W2077232248","https://openalex.org/W2082265886","https://openalex.org/W2083577108","https://openalex.org/W2084110692","https://openalex.org/W2093346797","https://openalex.org/W2105888718","https://openalex.org/W2107186809","https://openalex.org/W2110280696","https://openalex.org/W2110790733","https://openalex.org/W2125393689","https://openalex.org/W2125879914","https://openalex.org/W2139700140","https://openalex.org/W2145106442","https://openalex.org/W2145539378","https://openalex.org/W2145954079","https://openalex.org/W2147106280","https://openalex.org/W2151130840","https://openalex.org/W2152837663","https://openalex.org/W2153154672","https://openalex.org/W2155685026","https://openalex.org/W2156411508","https://openalex.org/W2158003600","https://openalex.org/W2168132298","https://openalex.org/W2777548161","https://openalex.org/W4320996190"],"related_works":["https://openalex.org/W2142389530","https://openalex.org/W1972106608","https://openalex.org/W2120273396","https://openalex.org/W3008734022","https://openalex.org/W3172534900","https://openalex.org/W4386789201","https://openalex.org/W2296450808","https://openalex.org/W7119342632","https://openalex.org/W2093754197","https://openalex.org/W7100038852"],"abstract_inverted_index":{"Non-motor":[0],"symptoms,":[1],"including":[2],"psychiatric":[3],"disorders,":[4],"are":[5,38,245],"increasingly":[6],"recognized":[7],"as":[8,47,144],"a":[9,32,57,188],"major":[10],"challenge":[11],"in":[12,24,56,69,87,98,105,124,150,154,164,239],"the":[13,25,29,65,70,88,101,125,139,151,155,165,181,197,204,228,231,240,248,262],"treatment":[14],"of":[15,28,35,54,64,111,136,215,230,247,250,267,277],"Parkinson's":[16],"disease":[17],"(PD).":[18],"These":[19],"ailments,":[20],"which":[21,80,176,217],"often":[22],"appear":[23],"early":[26,106],"stage":[27,107],"disease,":[30],"affect":[31,83],"large":[33],"number":[34],"patients":[36],"and":[37,129,160,173,199,235,264],"only":[39,76],"partly":[40],"resolved":[41],"by":[42,146,161,180,203,253,271],"conventional":[43],"antiparkinsonian":[44],"medications,":[45],"such":[46],"L-DOPA.":[48],"Here,":[49],"we":[50,259],"investigated":[51],"non-motor":[52],"symptoms":[53],"PD":[55],"mouse":[58],"model":[59,74],"based":[60],"on":[61,233,256],"bilateral":[62],"injection":[63,214],"toxin":[66],"6-hydroxydopamine":[67],"(6-OHDA)":[68],"dorsal":[71],"striatum.":[72],"This":[73],"presented":[75],"subtle":[77],"gait":[78],"modifications,":[79],"did":[81,169,225],"not":[82,170,226],"horizontal":[84],"motor":[85],"activity":[86],"open-field":[89,166],"test.":[90,167],"Bilateral":[91],"6-OHDA":[92,112],"lesion":[93,140,205,232],"also":[94,193],"impaired":[95],"olfactory":[96],"discrimination,":[97],"line":[99],"with":[100,206,210],"anosmia":[102],"typically":[103],"observed":[104],"parkinsonism.":[108],"The":[109],"effect":[110,229],"was":[113,192],"then":[114],"examined":[115],"for":[116],"mood-related":[117,243],"dysfunctions.":[118],"Lesioned":[119],"mice":[120],"showed":[121],"increased":[122,162],"immobility":[123],"forced":[126],"swim":[127],"test":[128],"tail":[130],"suspension":[131],"test,":[132,159],"two":[133],"behavioral":[134],"paradigms":[135],"depression.":[137],"Moreover,":[138],"exerted":[141],"anxiogenic":[142,200],"effects,":[143],"shown":[145],"reduced":[147],"time":[148],"spent":[149],"open":[152],"arms,":[153],"elevated":[156],"plus":[157],"maze":[158],"thigmotaxis":[163],"L-DOPA":[168],"modify":[171,227],"depressive-":[172,234],"anxiety-like":[174,236],"behaviors,":[175],"were":[177],"instead":[178],"counteracted":[179],"dopamine":[182,273,278],"D2/D3":[183],"receptor":[184],"agonist,":[185],"pramipexole.":[186],"Reboxetine,":[187],"noradrenaline":[189,223,251],"reuptake":[190],"inhibitor,":[191],"able":[194],"to":[195,213,221],"revert":[196],"depressive":[198],"effects":[201],"produced":[202],"6-OHDA.":[207,254],"Interestingly,":[208],"pre-treatment":[209],"desipramine":[211],"prior":[212],"6-OHDA,":[216],"is":[218,269],"commonly":[219],"used":[220],"preserve":[222],"neurons,":[224],"behaviors.":[237],"Thus,":[238],"present":[241],"model,":[242],"conditions":[244],"independent":[246],"reduction":[249],"caused":[252],"Based":[255],"these":[257],"findings":[258],"propose":[260],"that":[261],"anti-depressive":[263],"anxiolytic":[265],"action":[266],"reboxetine":[268],"mediated":[270],"promoting":[272],"transmission":[274],"through":[275],"blockade":[276],"uptake":[279],"from":[280],"residual":[281],"noradrenergic":[282],"terminals.":[283]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":13},{"year":2024,"cited_by_count":37},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":17},{"year":2021,"cited_by_count":19},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":19},{"year":2018,"cited_by_count":13},{"year":2017,"cited_by_count":18},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":8}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}